Psychopharmacology for Eating Disorder
- Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), are recommended as initial pharmacotherapy by most guidelines for the treatment of Bulimia Nervosa (BN) and Binge Eating Disorder (BED)
- Topiramate has positive outcome and efficacy data in the treatment of BN and BED, and lisdexamfetamine is FDA approved in the treatment of BED
- Olanzapine is recommended as adjunctive treatment for patients with anorexia nervosa (AN) who do not restore healthy body weight with nutritional rehabilitation plus psychotherapy.
- SSRIs may be used to treat co-morbid depression and anxiety in patients with AN once a healthy body weight is restored.